Robots ready for upcoming mission
The U.S. Food and Drug Administration (FDA) announced the approval of the "Aletta" device, an autonomous robot designed to automate blood collection procedures in healthcare clinics, in order to reduce reliance on phlebotomists and enhance service efficiency. The robot utilizes infrared and ultrasound technologies to locate the vein and independently performs most steps of blood draw after pinpointing the site, with a trained technician supervising. Clinical data has demonstrated that the performance in blood collection using Aletta either surpasses or matches that of human technicians, addressing the growing shortage of phlebotomists and emphasizing the improvement and increased efficiency of blood collection processes.
Notice: This Is an AI-Generated Summary
Comments (0)